Atlas FDA

In vitro Test TDx/TDxFLx Cyclosporine Monoclonal Whole Blood Reagent Pack 100 test TDx/TDxFLx Cyclosporine Monoclonal Wh

FDA device recall Z-0624-06 · posted 2006-03-15 · Terminated

Recall details

Recalling firm
Abbott Health Products, Inc.
Reason for recall
Patient results reported using calibrators made from new primary material may be falsely decreased by 5-8% compared to results using calibrators made from the previous primary material. An Important Product Information Letter with technical information regarding the Whole Blood Calibrators and Controls, implementing new internal reference standards was issued.
Action taken
Abbott has recently implemented new internal reference standards for TDx/TDxFLx Cyclosporine monoclonal Whole Blood Calibrators and Controls. A change in performance is associated with the use of calibrator lots 1829Q100 and higher and control lots 18230Q100 and higher, which are the first lots manufactured using the new internal reference standards. The specific performance changes are identified in the letter, dated March 23, 2005, as compared to current product using the previous standards (calibrators lot 05434Q100 and control lot 03071Q100).
Root cause
Other
Status
Terminated
Product code
MGU
Quantity affected
4,514 kits were distributed
Distribution
Nationwide, Puerto Rico, Hawaii, Mexico, Guatemala, Costa Rica, Venezuela, Colombia, Chile, Uruguay, Argentina, Brazil, Dominican Republic, Canada, Germany, Japan , Singapore, India, Taiwan, Thailand,
Date initiated
2005-03-23
Date posted
2006-03-15
Date terminated
2012-01-27
Location
Barceloneta, PR

Monitor recalls programmatically

Recalls and clearances share one API, with change alerts when new recalls post.